Pediatric cancer relapse prediction has taken a significant leap forward with the application of advanced AI technologies, offering hope for improved outcomes in young patients battling malignancies such as gliomas.A recent study conducted by researchers at Mass General Brigham has demonstrated that this innovative AI tool provides more precise predictions regarding relapse risks compared to traditional methods.